A multi-center randomized controlled clinical trial on treatment of chronic hepatitis C using Vitamin D combine pegylated-interferon alfa-2a+ ribavirin

Trial Profile

A multi-center randomized controlled clinical trial on treatment of chronic hepatitis C using Vitamin D combine pegylated-interferon alfa-2a+ ribavirin

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Vitamin D analogues (Primary) ; Peginterferon alfa-2a; Ribavirin
  • Indications Hepatitis C
  • Focus Pharmacodynamics
  • Most Recent Events

    • 29 Jul 2014 Status changed from not yet recruiting to completed as reported by Chinese Clinical Trial Register.
    • 21 May 2012 Planned end date (31 Dec 2013) added as reported by Chinese Clinical Trial Register.
    • 03 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top